Quantification of the influence of drugs on zebrafish larvae swimming kinematics and energetics

The use of zebrafish larvae has aroused wide interest in the medical field for its potential role in the development of new therapies. The larvae grow extremely quickly and the embryos are nearly transparent which allows easy examination of its internal structures using fluorescent imaging techniques. Medical treatment of zebrafish larvae can directly influence its swimming behaviours. These behaviour changes are related to functional changes of central nervous system and transformations of the zebrafish body such as muscle mechanical power and force variation, which cannot be measured directly by pure experiment observation. To quantify the influence of drugs on zebrafish larvae swimming behaviours and energetics, we have developed a novel methodology to exploit intravital changes based on observed zebrafish locomotion. Specifically, by using an in-house MATLAB code to process the recorded live zebrafish swimming video, the kinematic locomotion equation of a 3D zebrafish larvae was obtained, and a customised Computational Fluid Dynamics tool was used to solve the fluid flow around the fish model which was geometrically the same as experimentally tested zebrafish. The developed methodology was firstly verified against experiment, and further applied to quantify the fish internal body force, torque and power consumption associated with a group of normal zebrafish larvae vs. those immersed in acetic acid and two neuroactive drugs. As indicated by our results, zebrafish larvae immersed in 0.01% acetic acid display approximately 30% higher hydrodynamic power and 10% higher cost of transport than control group. In addition, 500 μM diphenylhydantoin significantly decreases the locomotion activity for approximately 50% lower hydrodynamic power, whereas 100 mg/L yohimbine has not caused any significant influences on 5 dpf zebrafish larvae locomotion. The approach has potential to evaluate the influence of drugs on the aquatic animal’s behaviour changes and thus support the development of new analgesic and neuroactive drugs

Phase diagram and exotic spin-spin correlations of anisotropic Ising model on the Sierpi\'nski gasket

The anisotropic antiferromagnetic Ising model on the fractal Sierpi\'{n}ski gasket is intensively studied, and a number of exotic properties are disclosed. The ground state phase diagram in the plane of magnetic field-interaction of the system is obtained. The thermodynamic properties of the three plateau phases are probed by exploring the temperature-dependence of magnetization, specific heat, susceptibility and spin-spin correlations. No phase transitions are observed in this model. In the absence of a magnetic field, the unusual temperature dependence of the spin correlation length is obtained with $0 \leq$J$_b/$J$_a<1$, and an interesting crossover behavior between different phases at J$_b/$J$_a=1$ is unveiled, whose dynamics can be described by the J$_b/$J$_a$-dependence of the specific heat, susceptibility and spin correlation functions. The exotic spin-spin correlation patterns that share the same special rotational symmetry as that of the Sierpi\'{n}ski gasket are obtained in both the $1/3$ plateau disordered phase and the $5/9$ plateau partially ordered ferrimagnetic phase. Moreover, a quantum scheme is formulated to study the thermodynamics of the fractal Sierpi\'{n}ski gasket with Heisenberg interactions. We find that the unusual temperature dependence of the correlation length remains intact in a small quantum fluctuation.Comment: 9 pages, 12 figure

JOINT POWER AND ITS RELATIONSHIP TO THE FATIGUE OF HUMAN BODY

In this study, the joint power and its relationship to levels of fatigue in the human body during vertical jumps was examined. The jumping movements, which were performed before and after a 30-second period of pedaling on a Monark bicycle ergometer, were video recorded. The video materials were then analyzed on a motion analysis system. The ground reaction force during jump was measured by a force platform. The joint power was calculated using the data from the above systems. The two groups of data were compared. The variation of joint power at each joint was computed and a quantitative description of the resulting fatigue was obtained

Genome-wide in silico identification and analysis of cis natural antisense transcripts (cis-NATs) in ten species

We developed a fast, integrative pipeline to identify cis natural antisense transcripts (cis-NATs) at genome scale. The pipeline mapped mRNAs and ESTs in UniGene to genome sequences in GoldenPath to find overlapping transcripts and combining information from coding sequence, poly(A) signal, poly(A) tail and splicing sites to deduce transcription orientation. We identified cis-NATs in 10 eukaryotic species, including 7830 candidate sense–antisense (SA) genes in 3915 SA pairs in human. The abundance of SA genes is remarkably low in worm and does not seem to be caused by the prevalence of operons. Hundreds of SA pairs are conserved across different species, even maintaining the same overlapping patterns. The convergent SA class is prevalent in fly, worm and sea squirt, but not in human or mouse as reported previously. The percentage of SA genes among imprinted genes in human and mouse is 24–47%, a range between the two previous reports. There is significant shortage of SA genes on Chromosome X in human and mouse but not in fly or worm, supporting X-inactivation in mammals as a possible cause. SA genes are over-represented in the catalytic activities and basic metabolism functions. All candidate cis-NATs can be downloaded from

An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells

<p>Abstract</p> <p>Background</p> <p>Virus-binding activity is one of the important functions of fibronectin (FN). It has been reported that a high concentration of FN in blood improves the transmission frequency of hepatitis viruses. Therefore, to investigate a protease that hydrolyzes FN rapidly is useful to decrease the FN concentration in blood and HBV infection. So far, however, no specific protease digesting FN in serum has been reported.</p> <p>Methods</p> <p>We employed a purified earthworm protease to digest serum proteins. The rapidly cleaved protein (FN) was identified by MALDI-TOF MS and western blotting. The cleavage sites were determined by N-terminus amino acid residues sequencing. The protease was orally administrated to rats to investigate whether serum FN <it>in vivo </it>became decreased. The serum FN was determined by western blotting and ELISA. In cytological studies, the protease was added to the medium in the culture of HepG2.2.15 cells and then HBsAg and HBeAg were determined by ELISA.</p> <p>Results</p> <p>The protease purified from earthworm <it>Eisenia fetida </it>was found to function as a fibronectinase (FNase). The cleavage sites on FN by the FNase were at R and K, exhibiting a trypsin alkaline serine-like function. The earthworm fibronectinase (EFNase) cleaved FN at four sites, R₂₅₉, R₁₀₀₅, K₁₅₅₇and R₂₀₃₉, among which the digested fragments at R₂₅₉, K₁₅₅₇and R₂₀₃₉were related to the virus-binding activity as reported. The serum FN was significantly decreased when the earthworm fibronectinase was orally administrated to rats. The ELISA results showed that the secretion of HBeAg from HepG2.2.15 cells was significantly inhibited in the presence of the FNase.</p> <p>Conclusion</p> <p>The earthworm fibronectinase (EFNase) cleaves FN much faster than the other proteins in serum, showing a potential to inhibit HBV infection through its suppressing the level of HBeAg. This suggests that EFNase is probably used as one of the candidates for the therapeutic agents to treat hepatitis virus infection.</p